Dr Elena Crisà/touchhaematology.com
Oct 19, 2025, 11:27
Future Leader 2025 – Dr Elena Crisà on Precision Medicine in Haematology
TMC (Touch Medical Communications) shared a post on LinkedIn:
“Future Leader 2025 – Dr Elena Crisà on Precision Medicine in Haematology
In this inspiring interview, Dr Elena Crisà (Candiolo Cancer Institute, Italy) discusses how precision medicine is transforming the diagnosis and treatment of acute myeloid leukaemia ( AML ).
From clinical trials to patient-centred care, Dr Crisà shares what drives her work and why aligning treatment with individual values is essential.”
Read the full feature here.
Stay updated with Hemostasis Today.
-
Nov 10, 2025, 10:16Pablo Corral on Enlicitide: The Phase 3 CORALreef HeFH Trial Brings a Major Step Forward
-
Nov 10, 2025, 10:15Laurent Bertoletti Invites You to the Joint INNOVTE and GITA Meeting on Hormones and Thrombosis
-
Nov 10, 2025, 10:15Christopher Cannon: DOAC Monotherapy Wins Again
-
Nov 10, 2025, 10:14Marieke Kruip on Sex differences in Outcomes of VKA Treatment in Patients with Mechanical Heart Valve
-
Nov 10, 2025, 10:14Ana Paula Lacombe: From Research to Bedside, Innovation in Stroke Care is Moving Fast!
-
Nov 10, 2025, 10:13Jan Sloves: Understanding Iliofemoral DVT – What You Can’t Afford to Miss
-
Nov 10, 2025, 10:12Mohamed Rawy Shares a Comprehensive Guide For Anticoagulation
-
Nov 10, 2025, 10:10Marc Carrier: Proud to Share the Results of the WAVe Study
-
Nov 10, 2025, 10:07Frederik Denorme – The New PI at the Laboratory of Cell Biology and Histology at University of Antwerp